vial semaglutide + Vitamin B12 5mg/ml (2ml vial) Compounded Semaglutide With B6 (Pyridoxine)

The broad, shortage-based compounding pathway ended after the FDA resolved the semaglutide and tirzepatide shortages, and in April 2026 the FDA proposed excluding these drugs from the 503B outsourcing-facility bulks list, with a comment period through June 29, 2026

Mounjaro: Early studies suggest it may outperform both in weight reduction

Moreover, because all participants received the combined intervention, it was not possible to disentangle the independent contributions of semaglutide and lifestyle modifications

That is always true regardless of concentration

We believe there should be a concerted field-wide effort to design studies that can answer gating questions for real-world GLP-1 deployment for addiction: what do clinicians need to know and see to increase confidence in using GLP-1s for patients with SUD or SUD risk